FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Strides Pharma Potassium Chloride Extended-Release Tablets Recall

Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only,…

Strides Pharma Inc. · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Oct 20, 2021
Recall ID
D-0006-2022
Check your lot numberHow we source this data

Summary

Strides Pharma recalled Potassium Chloride Extended-Release Tablets starting Sep 27, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0006-2022 on Oct 20, 2021. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun Limited, Bengaluru - 562106, India, Distributed by: Strides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07.

Lot numbers, UPCs & expiration codes

Lot 7240840A, exp. 12/31/2021

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0006-2022
Classification
Class II
Status
Terminated
Recall initiated
Sep 27, 2021
FDA report date
Oct 20, 2021
Quantity
1813 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Strides Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0006-2022, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
88759
Address
2 Tower Center Blvd Ste 1102
Code information
Lot 7240840A, exp. 12/31/2021
Postal code
08816-1100
Report date
Oct 20, 2021
Product type
Drugs
Recall number
D-0006-2022
Classification
Class II
Recalling firm
Strides Pharma Inc.
Product quantity
1813 bottles
Termination date
Oct 26, 2022
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun Limited, Bengaluru - 562106, India, Distributed by: Strides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07.
Distribution pattern
Nationwide
Recall initiation date
Sep 27, 2021
Initial firm notification
Letter
Center classification date
Oct 8, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0006-2022, published Oct 20, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls